[vc_row][vc_column][vc_column_text]<\/p>\n
La industria farmac\u00e9utica gasta millones de d\u00f3lares al a\u00f1o en la realizaci\u00f3n de estudios cl\u00ednicos y econ\u00f3micos con miras a probar la eficacia, la seguridad y la costo-efectividad de sus productos. Sin embargo, \u00bfcu\u00e1ntos de los resultados de estos estudios se transforman en herramientas \u00fatiles de acceso para los equipos de ventas? \u00bfSe est\u00e1 aprovechando toda la informaci\u00f3n de estas costosas inversiones en estrategias de acceso? La respuesta en muchos casos es no.<\/span><\/p>\n Orzan y cols en su art\u00edculo publicado en el Journal of Medicine and Life<\/em> en 2012 explican c\u00f3mo la industria farmac\u00e9utica ha empezado a utilizar t\u00e9cnicas de NeuroMarketing<\/em> para construir su estrategia de marketing y, por lo tanto, de acceso a los mercados. El marketing<\/em> se ha convertido en un proceso que sigue directrices cient\u00edficas, y est\u00e1 apoyado en la psicolog\u00eda cognitiva, las neurociencias, y la econom\u00eda del comportamiento. Estas disciplinas nos han ense\u00f1ado que en la medida en que conocemos c\u00f3mo funciona la mente de nuestros consumidores se pueden posicionar nuestros productos de una manera m\u00e1s eficaz.<\/p>\n Si su equipo entiende los mecanismos con los que decide el cerebro humano, los mecanismos con los que m\u00e9dicos y pacientes deciden y procesan la informaci\u00f3n, desde una perspectiva cient\u00edfica y \u00fatil, ser\u00e1 m\u00e1s f\u00e1cil construir campa\u00f1as efectivas de marketing<\/em>, y convertir los resultados de los estudios cl\u00ednicos y farmacoecon\u00f3micos en herramientas con un impacto real.<\/p>\n Nosotros podemos mostrarle c\u00f3mo hacerlo.<\/p>\n [\/vc_column_text][\/vc_column][\/vc_row]<\/p>\n","protected":false},"excerpt":{"rendered":" [vc_row][vc_column][vc_column_text] \u00bfC\u00f3mo convertir los estudios cl\u00ednicos y econ\u00f3micos en \u00fatiles herramientas de acceso? La industria farmac\u00e9utica gasta millones de d\u00f3lares al a\u00f1o en la realizaci\u00f3n…<\/p>\n","protected":false},"author":19,"featured_media":2307,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false,"_kad_blocks_custom_css":"","_kad_blocks_head_custom_js":"","_kad_blocks_body_custom_js":"","_kad_blocks_footer_custom_js":"","_kadence_starter_templates_imported_post":false,"_kad_post_transparent":"","_kad_post_title":"","_kad_post_layout":"","_kad_post_sidebar_id":"","_kad_post_content_style":"","_kad_post_vertical_padding":"","_kad_post_feature":"","_kad_post_feature_position":"","_kad_post_header":false,"_kad_post_footer":false,"_kad_post_classname":"","footnotes":""},"categories":[4,6],"tags":[],"ppma_author":[740],"class_list":["post-226","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-blog","category-news-sgsss"],"taxonomy_info":{"category":[{"value":4,"label":"Blogs Publicados"},{"value":6,"label":"Novedades SGSSS"}]},"featured_image_src_large":["https:\/\/neuroeconomix.com\/wp-content\/uploads\/2017\/01\/guias-clinicas.jpg",630,400,false],"author_info":{"display_name":"NeuroEconomix","author_link":"https:\/\/neuroeconomix.com\/es\/author\/wpnotifs\/"},"comment_info":0,"category_info":[{"term_id":4,"name":"Blogs Publicados","slug":"blog","term_group":0,"term_taxonomy_id":4,"taxonomy":"category","description":"","parent":0,"count":251,"filter":"raw","cat_ID":4,"category_count":251,"category_description":"","cat_name":"Blogs Publicados","category_nicename":"blog","category_parent":0},{"term_id":6,"name":"Novedades SGSSS","slug":"news-sgsss","term_group":0,"term_taxonomy_id":6,"taxonomy":"category","description":"","parent":0,"count":45,"filter":"raw","cat_ID":6,"category_count":45,"category_description":"","cat_name":"Novedades SGSSS","category_nicename":"news-sgsss","category_parent":0}],"tag_info":false,"authors":[{"term_id":740,"user_id":19,"is_guest":0,"slug":"wpnotifs","display_name":"NeuroEconomix","avatar_url":"https:\/\/neuroeconomix.com\/wp-content\/uploads\/2025\/01\/neuroeconomix-home-testimonials.svg","0":null,"1":"","2":"","3":"","4":"","5":"","6":"","7":"","8":""}],"_links":{"self":[{"href":"https:\/\/neuroeconomix.com\/es\/wp-json\/wp\/v2\/posts\/226","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/neuroeconomix.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/neuroeconomix.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/neuroeconomix.com\/es\/wp-json\/wp\/v2\/users\/19"}],"replies":[{"embeddable":true,"href":"https:\/\/neuroeconomix.com\/es\/wp-json\/wp\/v2\/comments?post=226"}],"version-history":[{"count":1,"href":"https:\/\/neuroeconomix.com\/es\/wp-json\/wp\/v2\/posts\/226\/revisions"}],"predecessor-version":[{"id":14454,"href":"https:\/\/neuroeconomix.com\/es\/wp-json\/wp\/v2\/posts\/226\/revisions\/14454"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/neuroeconomix.com\/es\/wp-json\/wp\/v2\/media\/2307"}],"wp:attachment":[{"href":"https:\/\/neuroeconomix.com\/es\/wp-json\/wp\/v2\/media?parent=226"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/neuroeconomix.com\/es\/wp-json\/wp\/v2\/categories?post=226"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/neuroeconomix.com\/es\/wp-json\/wp\/v2\/tags?post=226"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/neuroeconomix.com\/es\/wp-json\/wp\/v2\/ppma_author?post=226"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}